| Literature DB >> 32789821 |
Anna Hegerius1, Pia Caduff-Janosa2, Ruth Savage2,3,4, Johan Ellenius2.
Abstract
INTRODUCTION: An increasing global need for pharmacovigilance training cannot be met with classroom courses alone. Several e-learning modules have been developed by Uppsala Monitoring Centre (UMC). With distance learners and technological challenges such as poor internet bandwidth to be considered, UMC opted for the microlearning approach based on small learning units connected to specific learning objectives. The aim of this study was to evaluate how this e-learning course was received.Entities:
Year: 2020 PMID: 32789821 PMCID: PMC7424242 DOI: 10.1007/s40264-020-00981-w
Source DB: PubMed Journal: Drug Saf ISSN: 0114-5916 Impact factor: 5.606
The course modules, number of lessons and total duration of the video lessons
| Module | Number of lessons | Total duration (min) |
|---|---|---|
| 1. Introduction to signal detection | 6 | 15:46 |
| 2. Causality assessment of case safety reports | 7 | 25:19 |
| 3. Causality assessment of case series | 7 | 27:38 |
| 4. Signal assessment | 7 | 21:37 |
| 5. Statistical reasoning and algorithms in pharmacovigilance | 8 | 31:56 |
The modules are subdivided into lessons with specific learning objectives
Fig. 1Timeline of course development, launches and evaluations
Fig. 2World map showing the geographic spread of the learners for all modules
Fig. 3Overall ratings of modules 1–4 and module 5
Demographic profile of the learners who participated in the user surveys
| Demographic profile | Modules 1–4 (%) | Module 5 (%) |
|---|---|---|
| Residence (WHO region) | ||
| SEARO (South-East Asia) | 43.3 | 46.5 |
| EURO (Europe) | 24.2 | 23.5 |
| PAHO (The Americas) | 19.3 | 12.5 |
| AFRO (Africa) | 5.7 | 7.0 |
| EMRO (Eastern Mediterranean) | 4.9 | 8.0 |
| WPRO (Western Pacific) | 2.6 | 2.5 |
| Affiliation | ||
| Pharmaceutical company | 36.6 | 35.0 |
| PV centre (national or regional) | 22.6 | 16.0 |
| Academia (university, hospital) | 16.3 | 25.5 |
| Health organisation | 8.1 | 10.0 |
| Drug regulatory authority | 5.9 | 5.0 |
| Other | 10.4 | 8.5 |
| Profession | ||
| Pharmacist | 53.4 | 57.5 |
| Medical doctor | 21.5 | 18.5 |
| Other health professional | 9.1 | 5.5 |
| University student | 5.1 | 6.5 |
| Other | 10.8 | 12.0 |
PV pharmacovigilance, WHO World Health Organization
Comparison of the regional origins of survey respondents with those of the learners who were invited to participate in the surveys
| Residence (WHO region) | Modules 1–4 (%) | Module 5 (%) | ||
|---|---|---|---|---|
| Respondents | Learners | Respondents | Learners | |
| SEARO (South-East Asia) | 43.3 | 46.6 | 46.5 | 56.8 |
| EURO (Europe) | 24.2 | 17.3 | 23.5 | 14.4 |
| PAHO (The Americas) | 19.3 | 20.0 | 12.5 | 13.4 |
| AFRO (Africa) | 5.7 | 3.1 | 7.0 | 2.0 |
| EMRO (Eastern Mediterranean) | 4.9 | 5.5 | 8.0 | 10.3 |
| WPRO (Western Pacific) | 2.6 | 3.2 | 2.5 | 3.0 |
| Unknown | N/A | 4.2 | N/A | 0.2 |
N/A not applicable, WHO World Health Organization
Performance expectancy of the learners who participated in the user surveys
| Question | Answer option | Modules 1–4 (%) | Module 5 (%) |
|---|---|---|---|
| Do you perform signal assessments or related tasks in your daily work? | Yes | 64.6 | N/A |
| No | 35.4 | N/A | |
| Do you perform statistical signal detection or related tasks in your daily work? | Yes | N/A | 39.4 |
| No | N/A | 60.6 | |
| Will you be able to put what you have learnt into practice? | Yes, to a great extent | 51.4 | 32.3 |
| Yes, to some extent | 47.1 | 58.6 | |
| No, not really | 1.6 | 9.1 | |
| Was anything missing from the course? | Yes | 14.5 | 15.7 |
| No | 85.6 | 84.3 |
N/A not applicable
Effort expectancy of the learners who participated in the user surveys
| Question | Answer option | Modules 1–4 (%) | Module 5 (%) |
|---|---|---|---|
| Which device did you study on? (multiple answers possible) | Computer/laptop | 90.4 | 85.7 |
| iPad/tablet | 5.6 | 4.0 | |
| Mobile phone | 15.6 | 23.8 | |
| Was the learning platform easy to use? | Yes, very easy | 77.8 | 71.8 |
| Yes, fairly easy | 21.5 | 26.9 | |
| No, not very easy | 0.7 | 1.4 | |
| Did you experience any time lag when playing the lessons? | Yes | 16.7 | 14.5 |
| No | 83.3 | 85.5 | |
| Would you prefer to take the course in a different language? | Yes | 11.3 | N/A |
| No, English is fine | 88.7 | N/A | |
| Would you prefer subtitles in additional languages? | Yes | N/A | 24.6 |
| No, English and Spanish is fine | N/A | 75.4 |
N/A not applicable
Educational compatibility of the learners who participated in the user surveys
| Question | Answer option | Modules 1–4 (%) | Module 5 (%) |
|---|---|---|---|
| How would you rate the duration of the lessons? | Too short | 13.3 | 9.4 |
| Just right | 84.1 | 86.5 | |
| Too long | 2.7 | 4.2 | |
| How would you rate the visual look of the lessons? | Good, it aided my learning | 89.6 | 89.3 |
| Bad, it hindered my learning | 2.1 | 1.4 | |
| No comment | 8.3 | 9.4 | |
| Did the lecturers convey the content clearly? | Yes, everything was easy to follow | 65.5 | 53.3 |
| Yes, most of it was easy to follow | 33.9 | 45.2 | |
| No, it was difficult to follow | 0.6 | 1.4 | |
| Did the quiz questions aid your learning? | Yes | 93.8 | 90.5 |
| No | 1.7 | 4.3 | |
| I have not tried the quiz yet | 4.4 | 5.2 | |
| Did you use the transcripts? | Yes, always | 48.4 | N/A |
| Yes, sometimes | 40.3 | N/A | |
| No, never | 11.3 | N/A | |
| Would you appreciate the possibility to interact during the course? | Yes, with educators | 35.2 | 30.4 |
| Yes, with learners | 4.3 | 3.9 | |
| Yes, with educators and learners | 41.8 | 46.9 | |
| No, interaction is not needed | 18.7 | 18.8 |
N/A not applicable
| There is an increasing global need for pharmacovigilance training that cannot be met by classroom courses alone. |
| E-learning modules, using a microlearning approach to allow for distance learning and to address technological challenges, were developed, launched and evaluated. |
| Results of surveys to evaluate the modules, using a widely recognised model to predict technological and pedagogical acceptance, indicated a high level of satisfaction and suggestions for enhancement. |